Recommend an Eating Disorders or Obesity Prevention Program

Your Signature Assignment represents the culmination of your learning for the course. It allows you to apply the theories and concepts related to identifying at-risk populations for eating disorders or obesity and propose an awareness and prevention program.

Instructions

This week, imagine you work at a wellness center on a university campus. You are assigned the task of proposing a program to the wellness director on campus, to help prevent eating disorders or obesity in students who are identified as at risk for an eating disorder/obesity based on a preoccupation with weight and body shape / BMI. Please target your program to either men or women. If you have another target population that you would be interested in researching for this proposal, please contact your instructor to discuss alternative options.

Be sure your proposal covers the following:

• Discuss eating disorders / obesity within the target population.
• Include assessment of prevention programs.
• Include identification of at-risk populations.
• Address recruitment of at-risk populations.
• Include a sample advertisement for this program that could be used on the university website or Facebook page.
• Include a workshop outline.Specific features of your prevention program such as behavior modification
• Location
• Length
• Activities
• Discuss how this program may need to be adjusted to work with other populations.

Length: 12-15 pages, not including title and reference pages

Resources: Include a minimum of 7 – 10 scholarly resources, some of which you may have located as part of previous assignments. In addition to these specified resources, other appropriate scholarly resources may be included.

American Psychiatric Association. (2023). Practice guideline for the treatment of patients with eating disorders (4th ed.).

Fairburn, C. G. (2008). Cognitive behavior therapy and eating disorders. Guilford Press.

Hay, P., Mitchison, D., & Collado, A. E. (2017). Prevalence and burden of eating disorders: Current population estimates. Current Psychiatry Reports, 19(6), 41.

Lock, J., & Le Grange, D. (2015). Family-based treatment: Where are we and where should we be going? International Journal of Eating Disorders, 48(6), 721733.

Treasure, J., Duarte, T. A., & Schmidt, U. (2020). Eating disorders. The Lancet, 395(10227), 899911.

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing.

Rubino, F., Puhl, R. M., Cummings, D. E., Eckel, R. H., Ryan, D. H., Mechanick, J. I., Nadglowski, J., Salas, X. R., Schauer, P. R., Twenefour, D., Apovian, C. M., Aronne, L. J., Batterham, R. L., Berthoud, H.-R., Boza, C., Busetto, L., Dicker, D., De Groot, M., Eisenberg, D., … Dixon, J. B. (2020). Joint international consensus statement for ending stigma of obesity. Nature Medicine, 26(4), 485497.

Puhl, R. M., Lessard, L. M., & Himmelstein, M. S. (2020). Reducing weight stigma: What works? American Psychologist, 75(2), 227229. https://doi.org/10.1037/amp0000530

Powell-Wiley, T. M., Poirier, P., Burke, L. E., Desprs, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., St-Onge, M.-P., & American Heart Association Council on Lifestyle and Cardiometabolic Health. (2021). Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation, 143(21), e984e1010.

Wharton, S., Lau, D. C. W., Vallis, M., Sharma, A. M., Biertho, L., Campbell-Scherer, D., Adamo, K., Alberga, A., Bell, R., Boul, N., Boyling, E., Brown, J., Calam, B., Clarke, C., Crowshoe, L., Divalentino, D., Forhan, M., Freedhoff, Y., Gagner, M., … Rueda-Clausen, C. F. (2020). Obesity in adults: A clinical practice guideline. Canadian Medical Association Journal, 192(31), E875E891. https://doi.org/10.1503/cmaj.191707

Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 9891002.

Bray, G. A., Kim, K. K., & Wilding, J. P. H. (2017). Obesity: A chronic relapsing progressive disease process. Obesity Reviews, 18(7), 715723.

Garvey, W. T., et al. (2016). AACE/ACE clinical practice guidelines for obesity. Endocrine Practice, 22(Suppl. 3), 1203.

Jensen, M. D., et al. (2014). Management of overweight and obesity in adults. Circulation, 129(25), S102S138.

Puhl, R. M., & Heuer, C. A. (2010). Obesity stigma. Obesity, 18(8), 15281534.

Wadden, T. A., & Bray, G. A. (2018). Handbook of obesity treatment (2nd ed.). Guilford Press.

Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205216.